Latocom CF Eye Drop is a combination ophthalmic solution containing Timolol 5 mg/ml and Latanoprost 50 mcg/ml, indicated for the management of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Timolol, a non-selective beta-adrenergic receptor blocker, reduces aqueous humor production, thereby lowering IOP. Latanoprost, a prostaglandin F2α analogue, increases the outflow of aqueous humor through the uveoscleral pathway, contributing to further IOP reduction. The synergistic effect of these two agents provides enhanced efficacy compared to monotherapy with either component alone. Latocom CF Eye Drop is typically administered once daily in the affected eye(s), preferably in the evening, to optimize therapeutic outcomes. Caution is advised in patients with respiratory conditions such as asthma or chronic obstructive pulmonary disease, bradycardia, or heart block due to the beta-blocker component. Common adverse effects may include ocular irritation, hyperemia, blurred vision, and changes in iris pigmentation. Patients should be monitored regularly for response to therapy and potential side effects. Latocom CF Eye Drop should be used under the supervision of an ophthalmologist, ensuring adherence to prescribed dosing and contraindications to maximize safety and efficacy in glaucoma management.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.